DBV Technologies S.A.
DBVTF- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesDBVT
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DBV Technologies S.A. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $1.25K in total
- Insiders trading
- 1
- Net value
- −$1.25K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DBV Technologies S.A., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mohideen Pharis | Chief Medical Officer | 144,531 | Jul 31, 2026 | 3 |
| Baker Julian | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| Baker Felix | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| Baker Bros. Advisors LP | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| Baker Brothers Life Sciences LP | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| 667, L.P. | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| Baker Bros. Advisors (GP) LLC | Director | 14,575,984Indirect | Jan 14, 2026 | 1 |
| Caisse Des Depots Et Consignations | Other: Member of 10% owner group | 7,303,369Indirect | Dec 19, 2025 | 1 |
| Bpifrance Participations SA | Other: Member of 10% owner group | 7,303,369Indirect | Dec 19, 2025 | 1 |
| Bpifrance SA | Other: Member of 10% owner group | 7,303,369Indirect | Dec 19, 2025 | 1 |
| EPIC Bpifrance | Other: Member of 10% owner group | 7,303,369Indirect | Dec 19, 2025 | 1 |
| Bpifrance Investissement S.A.S. | Other: Member of 10% owner group | 7,303,369Indirect | Dec 19, 2025 | 1 |
| Tasse Daniel | CHIEF EXECUTIVE OFFICER | 17,094 | Nov 24, 2025 | 1 |
| Boucinha Virginie | Chief Financial Officer | 70,000 | Nov 24, 2025 | 1 |
| Trapp Kevin Michael | Chief Commercial Officer | 55,000 | Nov 24, 2025 | 1 |
| Ndu Adora | Director | 1,825 | Feb 8, 2024 | 0 |
| Morris Timothy E | Director | 12,000 | Aug 28, 2023 | 0 |
| Robitaille Sebastien | Chief Financial Officer | 36,500 | Aug 14, 2023 | 0 |
| Soland Daniel B | Director | 20,000 | Aug 3, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)4:15 PM ET | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −464 | $2.70 | −$1.25K | −0.3%144.5K after | |
| Feb 2, 2026 (view filing) | Jan 29 | 4 days | Mohideen PharisChief Medical Officer | SSale | −534 | $4.86 | −$2.60K | −0.4%145.0K after | |
| Dec 19, 2025 (view filing)4:04 PM ET | Dec 17-18 | 2 days | Caisse Des Depots Et Consignations and 4 othersOther: Member of 10% owner group | SSale | −3.37M | $4.60 | −$15.5M | −31.6%7.30M after | 3 lots |
| Nov 25, 2025 (view filing) | Nov 20-21 | 5 daysLate | Mohideen PharisChief Medical Officer | SSale | −8.12K | $2.86 | −$23.2K | −7.4%101.5K after | 2 lots |
| Jul 31, 2025 (view filing) | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −464 | $2.22 | −$1.03K | −0.4%109.6K after | |
| May 27, 2025 (view filing) | May 22 | 5 days | Mohideen PharisChief Medical Officer | SSale | −397 | $1.84 | −$730.48 | −0.4%110.1K after | |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | Mohideen PharisChief Medical Officer | SSale | −600 | $0.85 | −$510 | −0.5%110.5K after | |
| Nov 27, 2024 (view filing) | Nov 22-25 | 5 daysLate | Mohideen PharisChief Medical Officer | SSale | −907 | $0.5549 | −$503.31 | −0.8%111.1K after | 2 lots |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Mohideen PharisChief Medical Officer | SSale | −2.35K | $0.54 | −$1.27K | −2.1%112.0K after | |
| Jul 31, 2024 (view filing) | Jul 29 | 2 days | Mohideen PharisChief Medical Officer | SSale | −1.78K | $0.98 | −$1.75K | −2.2%79.4K after | |
| May 29, 2024 (view filing) | May 22-24 | 7 daysLate | Mohideen PharisChief Medical Officer | SSale | −1.04K | $1.37 | −$1.42K | −1.3%81.2K after | 2 lots |
| Mar 11, 2024 (view filing) | Mar 8 | 3 days | Tasse DanielCHIEF EXECUTIVE OFFICER | PPurchase | +17.1K | $0.83 | +$14.2K | New position17.1K after | |
| Feb 8, 2024 (view filing) | Feb 6 | 2 days | Ndu AdoraDirector | PPurchase | +1.82K | $0.89 | +$1.62K | New position1.82K after | |
| Dec 19, 2023 (view filing) | Nov 22 | 27 daysLate | Mohideen PharisChief Medical Officer | SSale | −2.25K | $1.74 | −$3.91K | −2.7%82.2K after | |
| Aug 28, 2023 (view filing) | Aug 25 | 3 days | Morris Timothy EDirector | PPurchase | +12.0K | $1.52 | +$18.2K | New position12.0K after | |
| Aug 14, 2023 (view filing) | Nov 24, 2022-May 24, 2023 | 263 daysLate | Mohideen PharisChief Medical Officer | SSale | −2.26K | $3.02 | −$6.82K | −4.4%49.4K after | 2 lots |
| Aug 3, 2023 (view filing) | Aug 1 | 2 days | Soland Daniel BDirector | PPurchase | +15.0K | $1.62 | +$24.3K | +300.0%20.0K after |